{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-075385","form_type":"8-K","ticker":"VCYT","cik":"0001384101","company_name":"VERACYTE, INC.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.015059+00:00","generated_at":"2026-06-04T09:00:12.250105+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Veracyte registers 1,016,965 shares for resale relating to C2i Genomics acquisition","bullets":["Filed prospectus supplement to register 1,016,965 shares of common stock for resale.","Shares were issued as part of the consideration for the February 5, 2024 acquisition of C2i Genomics.","Legal opinion from Fenwick & West LLP regarding the legality of the registered shares filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-075385","json":"https://secwatch.observer/filing/0001193125-24-075385.json","markdown":"https://secwatch.observer/filing/0001193125-24-075385.md","text":"https://secwatch.observer/filing/0001193125-24-075385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/0001193125-24-075385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/d735520d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:00:12.250105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}